rowid;session;analysis;userId;cube;Measures;GroupBy;Filters;nbCells
1;3C604A43A349CDC4130E5F83A8625EE6C83A2283F66A05BD44300AE9E67250DE;1;a;Films;[Sales Revenue];[Media];[Country=>[EQUAL Spain]];68
3;3C604A43A349CDC4130E5F83A8625EE6C83A2283F66A05BD44300AE9E67250DE;1;a;Films;[Sales Revenue];[Media];[Country=>[EQUAL Spain]];68
18;3C604A43A349CDC4130E5F83A8625EE6C83A2283F66A05BD44300AE9E67250DE;1;a;Films;[Sales Revenue];[Genre];[Country=>[EQUAL Spain]];57
19;3C604A43A349CDC4130E5F83A8625EE6C83A2283F66A05BD44300AE9E67250DE;1;a;Films;[Sales Revenue];[Genre];[Country=>[EQUAL Spain]];57
108;3C604A43A349CDC4130E5F83A8625EE6C83A2283F66A05BD44300AE9E67250DE;1;a;Films;[Sales Revenue];[Media];[Country=>[EQUAL Spain]];68
265;3C604A43A349CDC4130E5F83A8625EE6C83A2283F66A05BD44300AE9E67250DE;1;a;Films;[Sales Revenue];[Genre];[];59
268;3C604A43A349CDC4130E5F83A8625EE6C83A2283F66A05BD44300AE9E67250DE;1;a;Films;[Sales Revenue];[Genre];[Country=>[EQUAL Spain]];57
403;3C604A43A349CDC4130E5F83A8625EE6C83A2283F66A05BD44300AE9E67250DE;1;a;Films;[];[];[];0
